These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 25410378)
1. Accumulating evidence for a role of oxidized phospholipids in infectious diseases. Matt U; Sharif O; Martins R; Knapp S Cell Mol Life Sci; 2015 Mar; 72(6):1059-71. PubMed ID: 25410378 [TBL] [Abstract][Full Text] [Related]
2. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans. Leitinger N Subcell Biochem; 2008; 49():325-50. PubMed ID: 18751917 [TBL] [Abstract][Full Text] [Related]
5. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study. Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687 [TBL] [Abstract][Full Text] [Related]
6. Oxidized phospholipids as triggers of inflammation in atherosclerosis. Leitinger N Mol Nutr Food Res; 2005 Nov; 49(11):1063-71. PubMed ID: 16270279 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Reactive Oxygen Species: Double-Edged Weapon in Host Defense and Pathological Inflammation During Infection. Silwal P; Kim JK; Kim YJ; Jo EK Front Immunol; 2020; 11():1649. PubMed ID: 32922385 [TBL] [Abstract][Full Text] [Related]
8. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial. Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S; J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447 [TBL] [Abstract][Full Text] [Related]
9. Oxidized phospholipids in control of inflammation and endothelial barrier. Fu P; Birukov KG Transl Res; 2009 Apr; 153(4):166-76. PubMed ID: 19304275 [TBL] [Abstract][Full Text] [Related]
10. The role of oxidized phospholipids in the development of disease. Nie J; Yang J; Wei Y; Wei X Mol Aspects Med; 2020 Dec; 76():100909. PubMed ID: 33023753 [TBL] [Abstract][Full Text] [Related]
11. Regulation of inflammatory responses by oxidized phospholipids: structure-function relationships. Furnkranz A; Leitinger N Curr Pharm Des; 2004; 10(8):915-21. PubMed ID: 15032694 [TBL] [Abstract][Full Text] [Related]
12. The potential role of interleukin-37 in infectious diseases. Allam G; Gaber AM; Othman SI; Abdel-Moneim A Int Rev Immunol; 2020; 39(1):3-10. PubMed ID: 31633447 [TBL] [Abstract][Full Text] [Related]
13. Redox Biology of Infection and Consequent Disease. Isaguliants MG; Bartosch B; Ivanov AV Oxid Med Cell Longev; 2020; 2020():5829521. PubMed ID: 32089773 [No Abstract] [Full Text] [Related]
14. The role of oxidized phospholipids in atherosclerosis. Berliner JA; Leitinger N; Tsimikas S J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S207-12. PubMed ID: 19059906 [TBL] [Abstract][Full Text] [Related]
15. The regulation of inflammation by oxidized phospholipids. Freigang S Eur J Immunol; 2016 Aug; 46(8):1818-25. PubMed ID: 27312261 [TBL] [Abstract][Full Text] [Related]
16. Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids. Gao D; Podrez EA Free Radic Biol Med; 2018 Feb; 115():57-67. PubMed ID: 29155052 [TBL] [Abstract][Full Text] [Related]
17. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Kaczmarek A; Vandenabeele P; Krysko DV Immunity; 2013 Feb; 38(2):209-23. PubMed ID: 23438821 [TBL] [Abstract][Full Text] [Related]